TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
TCL Archive Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release April 26, 1985